» Articles » PMID: 14701873

Similar MLL-associated Leukemias Arising from Self-renewing Stem Cells and Short-lived Myeloid Progenitors

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2004 Jan 1
PMID 14701873
Citations 247
Authors
Affiliations
Soon will be listed here.
Abstract

We have used the hematopoietic system as a model to investigate whether acute myeloid leukemia arises exclusively from self-renewing stem cells or also from short-lived myeloid progenitors. When transduced with a leukemogenic MLL fusion gene, prospectively isolated stem cells and myeloid progenitor populations with granulocyte/macrophage differentiation potential are efficiently immortalized in vitro and result in the rapid onset of acute myeloid leukemia with similar latencies following transplantation in vivo. Regardless of initiating cell, leukemias displayed immunophenotypes and gene expression profiles characteristic of maturation arrest at an identical late stage of myelomonocytic differentiation, putatively a monopotent monocytic progenitor stage. Our findings unequivocally establish the ability of transient repopulating progenitors to initiate myeloid leukemias in response to an MLL oncogene, and support the existence of cancer stem cells that do not necessarily overlap with multipotent stem cells of the tissue of origin.

Citing Articles

The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development.

Sturgeon C, Wagenblast E, Izzo F, Papapetrou E Blood Cancer Discov. 2024; 6(2):94-109.

PMID: 39652739 PMC: 11876951. DOI: 10.1158/2643-3230.BCD-24-0235.


Prioritization of Eleven-Nineteen-Leukemia Inhibitors as Orally Available Drug Candidates for Acute Myeloid Leukemia.

Guo X, Atla S, Nyalata S, Alugubelli Y, Chen P, Xu S J Med Chem. 2024; 67(22):20100-20117.

PMID: 39530508 PMC: 11613437. DOI: 10.1021/acs.jmedchem.4c01337.


Integrated machine learning algorithms identify KIF15 as a potential prognostic biomarker and correlated with stemness in triple-negative breast cancer.

Guo Q, Qiu P, Pan K, Liang H, Liu Z, Lin J Sci Rep. 2024; 14(1):21449.

PMID: 39271768 PMC: 11399402. DOI: 10.1038/s41598-024-72406-y.


The dark side of stemness - the role of hematopoietic stem cells in development of blood malignancies.

Filipek-Gorzala J, Kwiecinska P, Szade A, Szade K Front Oncol. 2024; 14:1308709.

PMID: 38440231 PMC: 10910019. DOI: 10.3389/fonc.2024.1308709.


PHF6 loss reduces leukemia stem cell activity in an acute myeloid leukemia mouse model.

Yuan S, Gao M, Wang Y, Lan Y, Li M, Du Y Cancer Cell Int. 2024; 24(1):66.

PMID: 38336746 PMC: 10858464. DOI: 10.1186/s12935-024-03265-w.


References
1.
Orkin S . Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet. 2001; 1(1):57-64. DOI: 10.1038/35049577. View

2.
Ayton P, Cleary M . Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001; 20(40):5695-707. DOI: 10.1038/sj.onc.1204639. View

3.
Weissman I, Anderson D, Gage F . Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001; 17:387-403. DOI: 10.1146/annurev.cellbio.17.1.387. View

4.
Reya T, Morrison S, Clarke M, Weissman I . Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859):105-11. DOI: 10.1038/35102167. View

5.
Christensen J, Weissman I . Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A. 2001; 98(25):14541-6. PMC: 64718. DOI: 10.1073/pnas.261562798. View